The largest database of trusted experimental protocols

27 protocols using foetal bovine serum fbs

1

Cardiac Explant-Derived Cardiosphere Formation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human CSs were derived as previously described 12. In brief, heart tissues were minced into small pieces about 1–2 mm3, then washed with PBS and digested with collagenase solution for 15 min. (Sigma‐Aldrich, St. Louis, MO, USA), the tissue fragments were cultured as “cardiac explants” on plate coated with 0.25 mg/ml fibronectin (BD Biosciences, San Jose, CA, USA) in Iscove's modified Dulbecco's medium (IMDM; Invitrogen, Carlsbad, CA, USA). The IMDM media was supplemented with 20% foetal bovine serum (FBS; Corning, Corning, NY, USA), 0.5% Gentamicin (Gibco, Life Technologies, Durham, CA, USA), 0.1 mM 2‐mercaptoethanol (Invitrogen) and 1% L‐glutamine (Invitrogen). In about 1–2 weeks, a layer of stromal‐like flat cells, and phase‐bright round cells, emerged from the cardiac explant with phase‐bright cells over them. These cardiac explant‐derived cells were harvested using TryPEL Select (Gibco) and then seeded at a density of 2 × 104 cells/ml in poly‐d‐lysine‐coated flaks for cardiosphere formation. In about 3–5 days, explant‐derived cells spontaneously aggregated into cardiospheres. The morphology of cardiospheres was checked with a Nikon phase contrast microscope.
+ Open protocol
+ Expand
2

Immortalized Human Cardiomyocytes Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immortalized human cardiomyocytes cells were used as a cardiac model and purchased from Applied Biological Materials Inc. (abm). They derived from the ventricular tissue of 62 old years male. The culture media was composed of Dulbecco’s modified Eagle’s medium/Ham’s F12 50/50 mix containing 10% Foetal bovine serum (FBS), 100 U/ml penicillin, 100 U/ml streptomycin, 2 mM glutamine (Corning, Manassas, VA, USA) and it was replaced day by day. The cells (used at passage 4–8) were subcultured by 0.25% trypsin–EDTA (Corning, Manassas, VA, USA) enzymatic digestion. For cardiomyocytes characterization, cells were seeded in 10% FBS supplemented DMEM F12 at a seeding density of 2.5 × 104 cells/cm2. 24 h after seeding, 10% FBS supplemented DMEM F12 was replaced with the culture medium supplemented with 1% of FBS, which was changed every day until the sixth day. Then, human cardiomyocytes were exposed to NSAIDs of interest.
+ Open protocol
+ Expand
3

PAAD Cell Lines Culture Conditions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human PAAD cell lines SW1990, PANC1 and BXPC3 (Chinese Acad emy of Sciences Cell Bank, China), HEK-293T and human pancreatic ductal cell HPDE6C7 cell lines (Beina Culture Collection, China) were obtained. SW1990 (L-15, Gibco, USA), BXPC3 (RPMI 1640, HyClone, USA), PANC1, HPDE6C7 and HEK-293T (DMEM, HyClone, USA) were cul tured with 10% foetal bovine serum (FBS; Corning, USA) at 37°C with 5% CO 2 .
+ Open protocol
+ Expand
4

Human OSCC Cell Line Establishment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human OSCC cell line, HOC313, established from oral floor, was kindly provided by the Department of Oral and Maxillofacial Surgery, Graduate School of Medical Science, Kanazawa University (Ishikawa, Japan). Another human OSCC cell line, SAS, established from a human squamous cell carcinoma of the tongue,22 (link),23 was obtained from the RIKEN BioResource Center (Ibaraki, Japan). The human OSCC cell line, OSC-19, was obtained from Kanazawa University (Ishikawa, Japan). OSC-19 cells were transfected with the pmR-ZsGreen1 (Takara Bio, Shiga, Japan) vector, and the cell line that stably expresses green fluorescent protein (GFP), OSC-19-GFP, was established. The human keratinocyte line, HaCaT, was kindly provided by Dr. Shirasuna, at Kyushu University (Fukuoka, Japan). The cells were cultured in Dulbecco's Modified Eagle Medium (DMEM; Sigma) supplemented with 10% foetal bovine serum (FBS; Corning) and maintained under a humidified 5% CO2 atmosphere at 37 °C.
+ Open protocol
+ Expand
5

HMGB1-induced activation of immune cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs, LD-PBMCs, HD-PBMCs, NK, NK-T cells, monocytes, and YTS cells were grown in Serum Containing Medium (SCM) RPMI 1640 plus 10% Foetal Bovine Serum (FBS) (Corning, New York, NJ, USA) and penicillin/streptomycin 5% solution (Thermofisher Scientific, Waltham, MA, USA) and activated with IL-2 (Preprotech, London, UK) (200 U/mL) for 72 h at 37 °C and 5% CO2, and, afterwards, incubated with human HMGB1 (Sigma Aldrich, Saint Louis, MO, USA) (2 μg/mL) for 48 h at 37 °C, as already reported [68 (link)]. TLR2 and TLR4 inhibition were performed using an anti TLR2 blocking antibody (10 μg/mL) and TAK242 (100nM) (Invivogen, San Diego, CA, USA), as already reported [69 (link)]. Inhibitors were added 24 h before HMGB1 treatment, during IL-2 incubation.
+ Open protocol
+ Expand
6

Breast Cancer Cell Culture Conditions

Check if the same lab product or an alternative is used in the 5 most similar protocols
MDA-MB-231 cells were grown in Dulbecco’s Modified Eagle Medium (DMEM; Life Technologies, CA, USA) and HCC1143 cells were grown in Roswell Park Memorial Institute (RPMI) 1640 medium (Life Technologies, Carlsbad, CA, USA). Media was supplemented with 10% foetal bovine serum (FBS; Corning, Corning, NY, USA) and 1% penicillin-streptomycin solution (Life Technologies). MCF-12A cells were grown in MammoCult™ media supplemented with 5% FBS (Corning, NY, USA), 10% MammoCult™ proliferation supplement, 0.5% hydrocortisone and 0.2% heparin (all from Stem Cell Technologies, Vancouver, BC, Canada). MDA-MB-231-Luc cells were cultured in L-15 media supplemented with 15% FBS and 1% penicillin-streptomycin (Life Technologies, Carlsbad, CA, USA). A week before the animal experiment, the cells were harvested, washed in Dulbecco’s phosphate-buffered saline (DPBS, Gibco, Thermo Fisher Scientific, Waltham, MA, USA) and grown as mammospheres in MammoCult™ media (described below).
+ Open protocol
+ Expand
7

NRF2 Inhibition in Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cell lines used in this study were: human SKBR3 (breast cancer, carrying R175H p53 mutation), T98MG (glioblastoma, carrying M237I p53 mutation), MCF7 breast cancer, U87 glioblastoma, HCT116 and RKO colon cancer cell lines (all carrying wild-type p53), and HCT116 p53 null. The cells were cultured in either DMEM (Dulbecco modified Eagle’s medium) (Life Technologies-Invitrogen), or RPM1–1640 (Life Technologies-Invitrogen), with 10% heat-inactivated foetal bovine serum (FBS) (Corning, NY, USA, #35–079) and L-glutamine/streptomycin (100 μg/mL) (Corning, NY, USA, #30–002), in 5% CO2 at 37 °C. They were all mycoplasma negative. The NRF2 inhibitor Brusatol [47 (link)] (Sigma-Aldrich) was used at 100 nM, as previously reported [48 (link)].
+ Open protocol
+ Expand
8

Sulforaphane Modulation of Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human colon cancer HCT116, HCT116-p53−/− (kindly provided by Prof. Bert Volgelstein, Johns Hopkins University, Baltimore, MD, USA), colon cancer RKO and the human lung cancer H1299 (p53 null) cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM) (Life Technologies-Invitrogen, Eggenstein, Germany), containing 10% heat-inactivated Foetal Bovine Serum (FBS) (Corning, NY, USA) and L-glutamine/streptomycin (100 µg/mL) (Corning, NY, USA) in a culture incubator with 5% CO2 at 37 °C in humidified atmosphere. They underwent routine testing to ensure that they were mycoplasm negative. The activator of NRF2, that is, D,L-Sulforaphane (1-isothiocyanato-4-methylsulfinylbutane (SFN) (Sigma-Aldrich, St. Louise, MO, USA) [26 (link)] was dissolved in DMSO and used at various concentrations (1, 2, 5 µM) for 24 h, alone or in combination with drugs; chemotherapeutic drug cisplatin (CDDP) (Pharmachemie BV, The Netherlands) was added to the cell culture at 5 μg/mL, as previously reported [22 (link)]; and ZnCl2 (Sigma-Aldrich) was dissolved in dH2O2 and used at 100 μM [27 (link)].
+ Open protocol
+ Expand
9

Cell Culture and Hemisynthesis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For cell culture, Dulbecco modified Eagles minimal essential medium (DMEM)/HAM's F12 (F-12 Nutrient Medium) Glutamax, insulin, transferrin and selenium were obtained from Thermo Fisher (Waltham, MA, USA). Foetal bovine serum (FBS) was purchased from Corning (New York, NY, USA). Antibiotics (streptomycin and penicillin) and trypsin/EDTA were obtained from Lonza (Basel, Switzerland). The PA was purchased from Sigma-Aldrich (St Louis, MO, USA).
Concerning hemisynthesis and UPLC-DAD-MS analysis, acetobromo-α-Dglucuronic acid methyl-ester, pyridine and K 2 CO 3 were purchased from Sigma-Aldrich (Saint Quentin Fallavier, France); and ultra-pure methanol, ethanol, acetonitrile, ethyl acetate and formic acid were purchased from Fisher Scientific. Milli-Q water used for these experiments was produced in the laboratory using Purelab Ultra System (Elga Lab Water, High Wycombe, UK).
+ Open protocol
+ Expand
10

Analytical Standards of Bacopaside I and II

Check if the same lab product or an alternative is used in the 5 most similar protocols
The analytical standards bacopaside I (CAS No. 382148-47-2, 89.6% purity by HPLC, Lot no. 00002002-T17H) and bacopaside II (CAS No. 382146-66-9, 98% purity HPLC, Lot Number: 00002002-T17H), derived from the medicinal herb bacopa monnieri, were obtained from ChromaDex (Irvine, CA, USA), solubilised in methanol at 10 mM and 1.5 mM stock solutions, respectively, and stored at −20 °C. Cell lines MDA-MB-231, T47D, MCF7 and BT-474 were purchased from the American Type Culture Collection (ATCC; Manassas, VA, USA). Cells were maintained in complete medium, either in Dulbecco’s modified Eagle’s medium (DMEM; Life Technologies, Carlsbad, CA, USA) for MDA-MB-231, MCF7 and BT-474 or Roswell Park Memorial Institute (RPMI) 1640 medium (Life Technologies, Carlsbad, CA, USA) for T47D, containing 10% foetal bovine serum (FBS) (Corning, NY, USA), 200 U/mL of penicillin, 200 μg/mL of streptomycin (pen strep; Life Technologies, Carlsbad, CA, USA) and 2 mM L-alanyl-L-glutamine dipeptide (GlutaMAX Supplement; Life Technologies, Carlsbad, CA, USA). Cells were grown under standard culture conditions at 37° C with 5% CO2 in air and used within 4 passages.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!